Baidu
map

医学知识

订阅

MedSci主页 / 所有栏目 / 医学知识

7月20号，共有三种新冠疫苗经实验证明可以产生免疫反应！

2020-07-21 MedSci原创 MedSci原创

关注

7.20号，共有三种不同类型的冠状病毒疫苗经实验证明都可以产生预期的免疫反应，保护人们免受感染。

7月20号，《柳叶刀》同时发表了两篇疫苗临床实验结果，分别是牛津大学和阿斯利康公司开发的新冠疫苗的1/2期试验结果，中国公司CanSino Biologics生产的一种候选疫苗的2期结果。这两种疫苗经实验证明是安全的，并且能诱导免疫反应。

其中，牛津ChAdOx1 nCoV-19疫苗在28天内促使抗体反应，14天内促使T细胞反应。第一次注射疫苗后，大部分参与者可以产生中和抗体；在第二次注射疫苗后，所有参与者均产生中和抗体。

ELISA检测抗体反应

 

中国公司CanSino Biologics生产的Ad5载体COVID-19疫苗在28天内促使抗体反应。在这项研究中，单次注射1×1011病毒颗粒和5×1010病毒颗粒的Ad5载体COVID-19疫苗，分别诱导了59%和47%的参与者的中和抗体的血清转换，以及96%和97%的参与者的结合抗体的血清转换。1×1011病毒颗粒剂量组中95%的受试者和5×1010病毒颗粒剂量组中91%的受试者在接种后第28天出现细胞或体液免疫反应。

 

RBD的特异性抗体反应，接种后对COVID-19活病毒和伪病毒的中和抗体。

 

         

 用ELISpot测量的特异性T细胞反应

辉瑞和BioNTech生产的疫苗的1/2期试验的早期结果也在一篇尚未经过同行评审的预印论文中发布。

参考文献:

1，Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

DOI:https://doi.org/10.1016/S0140-6736(20)31604-4

2，Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2

DOI:https://doi.org/10.1016/S0140-6736(20)31605-6trial 

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2021-08-25 ms8000001467349717

    好消息

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2021-02-27 ms8000001094792874

    怎样才能让讯息提速？这都是半年前的事情了。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2020-09-21 子沐

    希望疫苗早点上市

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2020-08-19 ms8000001384237252

    好消息

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2020-07-30 岁月静好

    非常好

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2020-07-28 124d9e69m07暂无昵称

    好消息

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2020-07-27 你好

    厉害

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2020-07-23 清海

    希望中国的医学越来越好

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2020-07-23 cnxcy

    #免疫反应#

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1011531, encodeId=efec101153159, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77fe5585056, createdName=ms8000001467349717, createdTime=Wed Aug 25 23:13:32 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943930, encodeId=e883943930f2, content=怎样才能让讯息提速？这都是半年前的事情了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fede5446820, createdName=ms8000001094792874, createdTime=Sat Feb 27 14:38:36 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887123, encodeId=f31b88e12349, content=希望疫苗早点上市, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3592131933, createdName=子沐, createdTime=Mon Sep 21 16:15:05 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811107, encodeId=7ba881110e94, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aef5400210, createdName=ms8000001384237252, createdTime=Wed Aug 19 17:14:40 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805232, encodeId=3dfe805232c0, content=非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d61e5403714, createdName=岁月静好, createdTime=Thu Jul 30 18:35:26 CST 2020, time=2020-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804860, encodeId=5284804860c6, content=好消息, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94642520177, createdName=124d9e69m07暂无昵称, createdTime=Tue Jul 28 10:21:32 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804707, encodeId=7642804e0722, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:19:56 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804157, encodeId=49cc80415e6e, content=希望中国的医学越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200606/349b406026e84a52a04e2c5657420f5c/9d1de3d4fe3b45c5a1d927d1e00c012d.jpg, createdBy=da995381644, createdName=清海, createdTime=Thu Jul 23 17:23:00 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280220, encodeId=0bdc128022086, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Thu Jul 23 06:12:33 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028326, encodeId=63ee1028326cc, content=新冠肺炎，疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jul 21 18:12:33 CST 2020, time=2020-07-21, status=1, ipAttribution=)]
    2020-07-21 公卫新人

    新冠肺炎，疫情何时才能消失

    0

以上为热门评论，梅斯医学App还有更多内容
Baidu
map
Baidu
map
Baidu
map